Last reviewed · How we verify
Follicular fluid
At a glance
| Generic name | Follicular fluid |
|---|---|
| Sponsor | Nawara Mohamed Hashish |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Detection of Microplastics in Human Granulosa Cells and in the Follicular Fluid of Women Undergoing ICSI Treatment
- Cumulus Cell Mitochondrial Activity as a Non-invasive Marker of Embryo Quality (FLIM)
- Automation of the In Vitro Fertilization Laboratory (NA)
- Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
- Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors (PHASE1, PHASE2)
- The ROAR Study: Reactive Oxygen Species and Reproduction
- Melatonin Supplementation in Ovarian Response (NA)
- The Role of Follicular Flushing at Oocyte Retrieval (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Follicular fluid CI brief — competitive landscape report
- Follicular fluid updates RSS · CI watch RSS
- Nawara Mohamed Hashish portfolio CI